MENU

CNTX Context Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
CNTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
CNTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CNTX is expected to report earnings to rise 33.25% to -5 cents per share on November 07

Context Therapeutics CNTX Stock Earnings Reports
Q3'24
Est.
$-0.05
Q2'24
Beat
by $0.03
Q1'24
Beat
by $0.09
Q4'23
Missed
by $0.06
Q3'23
Missed
by $0.06
The last earnings report on August 07 showed earnings per share of -3 cents, beating the estimate of -6 cents. With 49.59K shares outstanding, the current market capitalization sits at 160.50M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
5
Web
https://www.contexttherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ODIYX115.04-0.08
-0.07%
Invesco Discovery Y
HDMBX13.88-0.02
-0.14%
Hartford Small Company HLS IB
LAAGX14.06-0.02
-0.14%
Lord Abbett International Growth A
GIEZX15.15-0.07
-0.46%
GuideStone Funds International Eq Inv
SFSLX26.11-0.14
-0.53%
1919 Financial Services C

CNTX and Stocks

Correlation & Price change

A.I.dvisor tells us that CNTX and FATE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
-0.47%
FATE - CNTX
30%
Poorly correlated
+10.72%
DSGN - CNTX
29%
Poorly correlated
+15.69%
CMMB - CNTX
29%
Poorly correlated
N/A
HRMY - CNTX
27%
Poorly correlated
+1.79%
TYRA - CNTX
25%
Poorly correlated
-0.28%
More